imipramine has been researched along with Gynecomastia in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Gynecomastia: Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendhekar, DN | 1 |
| Srilakshmi, P | 1 |
| Turkington, RW | 1 |
2 other studies available for imipramine and Gynecomastia
| Article | Year |
|---|---|
Olanzapine-induced gynecomastia.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Capgras Syndrome; Dr | 2005 |
Serum prolactin levels in patients with gynecomastia.
Topics: Adolescent; Adult; Amenorrhea; Animals; Caseins; Cell Line; Chlorpromazine; Choriocarcinoma; Gynecom | 1972 |